Textiles Press Releases
SEE OTHER BRANDS

Your best source on the textile industry news from the world

Textiles Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.

Press releases published on May 14, 2025

nCino Announces Timing of its First Quarter Fiscal Year 2026 Financial Results Conference Call

nCino Announces Timing of its First Quarter Fiscal Year 2026 Financial Results Conference Call

WILMINGTON, N.C., May 14, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, will report financial results for its first quarter ended April 30, 2025, after the market close on …

Moleculin Reports First Quarter 2025 Financial Results and Provides Corporate Update

Moleculin Reports First Quarter 2025 Financial Results and Provides Corporate Update

Enrollment and dosing underway in Phase 3 clinical trial (the “MIRACLE” trial) evaluating Annamycin (naxtarubicin) for the treatment of R/R AML  Regulatory and site selection progress to date supports interim data readout expected in the second half of …

LAVA Reports First Quarter 2025 Financial Results, Provides Business Update

LAVA Reports First Quarter 2025 Financial Results, Provides Business Update

Focused on evaluation of strategic alternatives, with restructuring and closure of the Netherlands operations Enrollment in LAVA-1266 Phase 1 continues to progress Cash, cash equivalents and short-term investments of $66.6 million as of March 31, 2025 …

Arbutus Reports First Quarter 2025 Financial Results and Provides Corporate Update

Arbutus Reports First Quarter 2025 Financial Results and Provides Corporate Update

Imdusiran combination therapy has functionally cured 8 patients with chronic hepatitis B (cHBV) to date, including 2 patients who received no interferon AB-101, oral small-molecule PD-L1 inhibitor, shown generally safe and well-tolerated with evidence of …

Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights

Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights

- Interim data from ENERGY 3 trial highlight INZ-701’s potential to modify disease course in ENPP1 Deficiency, with sustained phosphate increases and favorable safety and immunogenicity profile to date - - ENERGY 3 trial on track for topline data in first …

Erdene Announces Q1 2025 Results and Provides Bayan Khundii Project Update

Erdene Announces Q1 2025 Results and Provides Bayan Khundii Project Update

HALIFAX, Nova Scotia, May 14, 2025 (GLOBE NEWSWIRE) -- Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN) ("Erdene" or the "Company") is pleased to announce operating and financial results for the quarter ended March 31, 2025, and to provide an update …

[Latest] Global Pharmaceutical Container Market Size/Share Worth USD 189.45 Billion by 2034 at a 6.98% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[Latest] Global Pharmaceutical Container Market Size/Share Worth USD 189.45 Billion by 2034 at a 6.98% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, May 14, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Pharmaceutical Container Market Size, Trends and Insights By Product Type (Bottles, Vials …

PussFi Launches $PUSS: Turning Memes into Real-Utility Tokens!

PussFi Launches $PUSS: Turning Memes into Real-Utility Tokens!

DUBAI, United Arab Emirates, May 14, 2025 (GLOBE NEWSWIRE) -- PussFi has officially launched $PUSS, the first-ever meme-tility token (a meme coin with real-world utility), on Steemit, a decentralized social media platform. Built on the Tron blockchain, $ …

Peter Lambrinakos, O.O.M., CPP, Joins Draganfly’s Public Safety Advisory Board, Strengthening Canadian Leadership in Public Safety

Peter Lambrinakos, O.O.M., CPP, Joins Draganfly’s Public Safety Advisory Board, Strengthening Canadian Leadership in Public Safety

Veteran leader in public safety, national security, and critical infrastructure protection brings strategic, operational, and innovation expertise to advance Draganfly’s public safety mission Saskatoon, SK, May 14, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. ( …

Coppernico Confirms Large-Scale Copper Skarn System and Expands Pipeline of Priority Targets at Sombrero

Coppernico Confirms Large-Scale Copper Skarn System and Expands Pipeline of Priority Targets at Sombrero

VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- Coppernico Metals Inc. (TSX: COPR, OTCQB: CPPMF) (“Coppernico” or the “Company”), is pleased to report the remaining assay results from its Phase 1 drill program at its Sombrero Project in Peru. …

New Storage Facilities Under StorageMart and Manhattan Mini Storage Third Party Management in Q1 2025

New Storage Facilities Under StorageMart and Manhattan Mini Storage Third Party Management in Q1 2025

COLUMBIA, Mo., May 14, 2025 (GLOBE NEWSWIRE) -- StorageMart and Manhattan Mini Storage Third Party Management continue to be a growing presence in the self storage industry with the onboarding of several facilities in Q1 2025. These additions further …

Calian annonce les résultats du deuxième trimestre

Calian annonce les résultats du deuxième trimestre

(Tous les montants dans le communiqué sont en dollars canadiens.) OTTAWA, Ontario, 14 mai 2025 (GLOBE NEWSWIRE) -- CalianMD Group Ltd. (TSX : CGY), une société qui fournit des solutions essentielles à la mission, axée sur la défense, l’espace, les soins de …

Calian Reports Results for the Second Quarter

Calian Reports Results for the Second Quarter

(All amounts in release are in Canadian dollars) OTTAWA, Ontario, May 14, 2025 (GLOBE NEWSWIRE) -- Calian® Group Ltd. (TSX:CGY), a mission critical solutions company, with a focus on defence, space, healthcare and strategic growth markets, today released …

Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update

Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update

Resolution of CRL Manufacturing issues in progress - Type A meeting requested No clinical safety or efficacy concerns raised by FDA MONTREAL and CHARLOTTE, N.C., May 14, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported …

Pasithea Therapeutics Announces Initiation of Phase 1/1B Study of PAS-004 in Adult NF1 Patients and Activation of First Clinical Trial Site

Pasithea Therapeutics Announces Initiation of Phase 1/1B Study of PAS-004 in Adult NF1 Patients and Activation of First Clinical Trial Site

-- First patient expected to be dosed during Q2 2025 -- -- Trial will evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy in both plexiform neurofibromas and cutaneous neurofibromas -- -- Starting dose of 4mg tablet …

LeddarTech Announces the Launch of LeddarSim: Next Leap in Realistic Advanced Driver Assistance Systems (ADAS) and Autonomous Driving (AD) Simulation

LeddarTech Announces the Launch of LeddarSim: Next Leap in Realistic Advanced Driver Assistance Systems (ADAS) and Autonomous Driving (AD) Simulation

QUEBEC CITY, Canada, May 14, 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (“LeddarTech”) (Nasdaq: LDTC), an AI-powered software company recognized for its innovation in advanced driver assistance systems (ADAS) and autonomous driving (AD), is pleased …

LeddarTech annonce le lancement de LeddarSim : une nouvelle étape dans la simulation réaliste des systèmes avancés d’aide à la conduite (ADAS) et de conduite autonome (AD)

LeddarTech annonce le lancement de LeddarSim : une nouvelle étape dans la simulation réaliste des systèmes avancés d’aide à la conduite (ADAS) et de conduite autonome (AD)

QUÉBEC, Canada, 14 mai 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (« LeddarTech ») (NASDAQ : LDTC), une société de logiciels alimentés par l’IA et reconnue pour son innovation dans les systèmes avancés d’aide à la conduite (systèmes ADAS) et de …

Editas Medicine Reports New In Vivo Data Highlighting the Potential of Editas’ Gene Upregulation Strategy in HSCs at the American Society of Gene and Cell Therapy Annual Meeting

Editas Medicine Reports New In Vivo Data Highlighting the Potential of Editas’ Gene Upregulation Strategy in HSCs at the American Society of Gene and Cell Therapy Annual Meeting

Data demonstrate therapeutically relevant editing levels using a clinically validated strategy, supporting its development as a novel, in vivo approach to treating sickle cell disease and beta thalassemia CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- …

Invivyd Files Citizen Petition Urging FDA to Focus on Monoclonal Antibodies For Endemic-Virus-Era COVID-19 Prevention, and to Re-Assess COVID-19 Vaccine Efficacy

Invivyd Files Citizen Petition Urging FDA to Focus on Monoclonal Antibodies For Endemic-Virus-Era COVID-19 Prevention, and to Re-Assess COVID-19 Vaccine Efficacy

WALTHAM, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced it has submitted a Citizen Petition with the U.S. Food and Drug Administration (FDA) calling on the Agency to evolve from historical approaches to the development …

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025

Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise, with key data readouts expected this year ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy type 1 (NT1), narcolepsy type 2 (NT2) and idiopathic …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service